Currently, the potential for cardiovascular (CV) stress-induced risk is primarily
based on the theoretical (obvious) side effects of stress on the CV system. Salivary
cortisol and α-amylase, produced respectively by the hypothalamus-pituitary-adrenal
(HPA) axis and the sympathetic-adrenomedullary (SAM) system during stress response,
are still not included in the routine evaluation of CV risk and require additional
and definitive validation. Therefore, this article overviews studies published
between 2010 and 2015, in which salivary cortisol and α-amylase were measured as
stress biomarkers to examine their associations with CV/CMR (cardiometabolic risk)
clinical and subclinical indicators. A comprehensive search of PubMed, Web of Science
and Scopus electronic databases was performed, and 54 key articles related to the use
of salivary cortisol and α-amylase as subclinical indicators of stress and CV/CMR
factors, including studies that emphasized methodological biases that could influence
the accuracy of study outcomes, were ultimately identified. Overall, the biological
impact of stress measured by salivary cortisol and α-amylase was associated with
CV/CMR factors. Results supported the use of salivary cortisol and α-amylase as
potential diagnostic tools for detecting stress-induced cardiac diseases and
especially to describe the mechanisms by which stress potentially contributes to the
pathogenesis and outcomes of CV diseases.